Drug level assessed as human recombinant FMO5-mediated compound formation from 10 uM ER-879819 in presence NADH after 60 mins by LC-MS/MS method

Basic Information

ID: ALA3531400

Type: ADME

Description: Drug level assessed as human recombinant FMO5-mediated compound formation from 10 uM ER-879819 in presence NADH after 60 mins by LC-MS/MS method

Format: BAO_0000357

Organism: Homo sapiens

Target: Dimethylaniline monooxygenase [N-oxide-forming] 5(ALA3430871)

Document: ALA3525952

Drug level assessed as human recombinant FMO5-mediated compound formation from 10 uM ER-879819 in presence NADH after 60 mins by LC-MS/MS method: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA3531400

Drug metabolism

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
381.39	1.96	1.96

Parent Molecular Weight

ALogP

Polar Surface Area

381.39

1.96

Drug level assessed as human recombinant FMO5-mediated compound formation from 10 uM ER-879819 in presence NADH after 60 mins by LC-MS/MS method

Basic Information

Activity Charts

Compound Summary